Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:32 AM
Ignite Modification Date:
2025-12-25 @ 12:32 AM
NCT ID:
NCT00310167
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Histologically confirmed follicular or mmarginal zone non-Hodgkin's lymphoma (NHL)
* Any stage
* Radiotherapy is indicated for curative treatment of stage IA or IIA disease OR palliation due to tumor bulk or anatomical position
PATIENT CHARACTERISTICS:
* Life expectancy \> 3 months
PRIOR CONCURRENT THERAPY:
* More than 4 weeks since prior chemotherapy
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00310167
Study Brief:
Protocol Section:
NCT00310167